Answer
Opicapone (Ongentys) is used as adjunctive therapy to levodopa/DOPA decarboxylase inhibitor combinations in adults with Parkinson’s disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.
Sources for this answer
- Ongentys 50 mg hard capsulesBial Pharma UK Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 7Document updated
Sources checked